Market Place
Sourcing Support
Daxor Utilizes Medaxiom Transforum To Boost Blood Volume Analysis
28 Apr 2026 //
GLOBENEWSWIRE
Daxor Validates Blood Volume Analysis Metric At SCCM 2026
26 Mar 2026 //
GLOBENEWSWIRE
Daxor to Showcase Next-Generation Portable Blood Volume Analyzer
17 Mar 2026 //
GLOBENEWSWIRE
Daxor Unveils Portable Blood Volume Analyzer At SCCM 2026
10 Mar 2026 //
GLOBENEWSWIRE
Daxor Corp Joins Iaccess Virtual Alpha Best Ideas Spring
09 Mar 2026 //
GLOBENEWSWIRE
Daxor CEO Feldschuh Shares Progress in Letter to Shareholders
03 Mar 2026 //
GLOBENEWSWIRE
Daxor Reports 45% Revenue Growth, $9.07 NAV for 2025
03 Mar 2026 //
GLOBENEWSWIRE
Daxor Expands Outpatient Reach, Introduces BVA Diagnostic
24 Feb 2026 //
GLOBENEWSWIRE
Daxor Corp Transitions to Exchange Act Reporting
10 Feb 2026 //
GLOBENEWSWIRE
Daxor Corporation Announces $9 Million Registered Direct Offering
23 Jan 2026 //
GLOBENEWSWIRE
Daxor Expands With 3 Facility Adoptions & Next-Gen BVA Analyzer
25 Nov 2025 //
GLOBENEWSWIRE
Daxor CEO Feldschuh To Present At Maxim Growth Summit
21 Oct 2025 //
GLOBENEWSWIRE
Daxor to Present New BVA Tech at MedAxiom CV Transforum 25
15 Oct 2025 //
GLOBENEWSWIRE
Daxor Launches Fda-Cleared Bva Analyzer Amid High Demand And Key
30 Sep 2025 //
GLOBENEWSWIRE
Daxor Corp Unveils Next-Gen BVA Analyzer at HFSA Meeting
23 Sep 2025 //
GLOBENEWSWIRE
Daxor Blood Volume Analysis Validated in COVID, Sepsis
04 Sep 2025 //
GLOBENEWSWIRE
Daxor CEO Michael Feldschuh Provides 1st Half Corporate Update
02 Sep 2025 //
GLOBENEWSWIRE
Daxor Corp`s Replay of Nasdaq Closing Bell Ceremony Now Available
12 Aug 2025 //
GLOBENEWSWIRE
FDA Clears Daxor Corp`s New Rapid, Lightweight Blood Volume
07 Aug 2025 //
GLOBENEWSWIRE
Daxor’s Blood Volume Tech Adopted by Three Centers
22 Jul 2025 //
GLOBENEWSWIRE
Daxor Expands Blood Volume Diagnostics to Two U.S. Systems
13 May 2025 //
GLOBENEWSWIRE
Florida Healthcare Leader Adopts Daxor Blood Volume Analysis Tech
07 May 2025 //
GLOBENEWSWIRE
Daxor Corporation to Exhibit at ISHLT Annual Meeting
22 Apr 2025 //
GLOBENEWSWIRE
Daxor to Showcase Blood Volume Analysis at MedAxiom 2025
17 Apr 2025 //
GLOBENEWSWIRE
Daxor Study Shows 2.6x Survival in Euvolemic HF Patients
15 Apr 2025 //
GLOBENEWSWIRE
Daxor submits 510(k) to FDA for Blood Volume Analyzer
10 Apr 2025 //
GLOBENEWSWIRE
Daxor Corp. Reveals Duke Data, BVA Insights at ACC`s 74th Expo
02 Apr 2025 //
GLOBENEWSWIRE
Daxor expands blood volume analysis in Midwest, New Jersey
28 Mar 2025 //
GLOBENEWSWIRE
Daxor Reports NAV At $7.25, 116.5% Revenue Growth In 2023
04 Mar 2025 //
GLOBENEWSWIRE
Daxor CEO Michael Feldschuh Updates Shareholders In New Letter
04 Mar 2025 //
GLOBENEWSWIRE
Daxor Corporation CEO Michael Feldschuh Provides Shareholder Upda
04 Mar 2025 //
GLOBENEWSWIRE
Daxor Corporation Investor Call on March 6, 2025
04 Mar 2025 //
GLOBENEWSWIRE
Daxor Reports NAV Rise To $7.25, 116.5% Revenue Growth In 2024
04 Mar 2025 //
GLOBENEWSWIRE
Daxor Expands Blood Volume Analysis At Major Midwest Center
28 Feb 2025 //
GLOBENEWSWIRE
Daxor Corp. Expands Blood Volume Analysis to NJ Hospitals
27 Feb 2025 //
GLOBENEWSWIRE
Daxor Shares Blood Volume Analysis Data From Duke, Yale At THT 2025
19 Feb 2025 //
GLOBENEWSWIRE
Daxor to Exhibit at World`s Largest Critical Care Conference
18 Feb 2025 //
GLOBENEWSWIRE
Daxor’s Blood Volume Analysis Identifies Hidden Heart Failure
14 Feb 2025 //
GLOBENEWSWIRE
Study Highlights Daxor’s Blood Volume Analysis In Heart Failure Care
13 Feb 2025 //
GLOBENEWSWIRE
Daxor Expands BVA-100™ to Two New Hospital Systems
18 Dec 2024 //
GLOBENEWSWIRE
Daxor`s BVA-100 Featured At MedAxiom CV Transforum Fall `24
09 Oct 2024 //
GLOBENEWSWIRE
Daxor To Participate In Maxim Healthcare Virtual Summit
08 Oct 2024 //
GLOBENEWSWIRE
Daxor Corporation Streamlines Regulatory Strategy For Device
27 Sep 2024 //
GLOBENEWSWIRE
Daxor Corporation To Exhibit At Heart Failure Society Meeting
19 Sep 2024 //
GLOBENEWSWIRE
Daxor`s Blood Volume Analysis Key In Cardiorenal Syndrome Management
12 Sep 2024 //
GLOBENEWSWIRE
Daxor Receives $300K Award From Launch Tennessee
05 Sep 2024 //
GLOBENEWSWIRE
Florida Hospital Implements Daxor`s BVA-100 For Heart Failure
04 Sep 2024 //
GLOBENEWSWIRE
Daxor to Present at H.C. Wainwright Global Investment Conference
03 Sep 2024 //
GLOBENEWSWIRE
Daxor CEO Michael Feldschuh Provides Corporate Update in Shareholder Letter
03 Sep 2024 //
GLOBENEWSWIRE
Daxor Launches BVA Program at Mid-South`s Largest Integrated Network
29 Aug 2024 //
GLOBENEWSWIRE
Daxor Awarded $1.9M USAF Contract For Blood Volume Analyzer
06 Aug 2024 //
GLOBENEWSWIRE
Daxor Expands To Three New Facilities For Blood Volume Analysis
05 Aug 2024 //
GLOBENEWSWIRE
Daxor Gets New Contract From Defense Health Agency For Analyzer
24 Jul 2024 //
GLOBENEWSWIRE
Daxor`s BVA-100™ Blood Volume Diagnostic Expands To Three New Centers
11 Jul 2024 //
GLOBENEWSWIRE
Daxor To Showcase BVA-100™ Guided-Care At AAHFN 20th Annual Meeting
18 Jun 2024 //
GLOBENEWSWIRE
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
05 Jun 2024 //
GLOBENEWSWIRE
Daxor`s BVA-100 Diagnostic Proves Clinical Benefits in Ambulatory Heart Failure
16 Apr 2024 //
GLOBENEWSWIRE
DAXOR At MedAxiom CardioVascular Conference For BVA Adoption
15 Apr 2024 //
GLOBENEWSWIRE
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
10 Apr 2024 //
GLOBENEWSWIRE
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
01 Apr 2024 //
GLOBENEWSWIRE
